Zhong Ji Longevity’s Major Financial Move Requires Approval

Zhong Ji Longevity Science Group Limited (HK:0767) has released an update.

Zhong Ji Longevity Science Group Limited has clarified that its 2025 Revolving Loan Agreement constitutes a major transaction, necessitating further approval and disclosure under Hong Kong’s Listing Rules. This development highlights a substantial financial move by the company, potentially impacting their stock and investor interest due to the increased regulatory scrutiny and required shareholder approval.

For further insights into HK:0767 stock, check out TipRanks’ Stock Analysis page.